Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
10/1997
10/29/1997EP0802908A1 Novel compounds
10/29/1997EP0802794A1 Modulators of pneumococcal adherence to pulmonary and vascular cells and diagnostic and therapeutic applications
10/29/1997EP0493380B1 Method and compositions for noninvasive dose-to-effect administration of lipophilic drugs
10/29/1997CN1163571A Compositions containing at least one glucocorticoid in combination with pulmonary surfactant for treatment of IRDS and ARDS
10/29/1997CN1163268A Quinolinone derivatives and antianaphylactic agent containing said quinolinone devivative as biological active component
10/29/1997CN1163131A Fengdan oral liquid and its preparation process
10/28/1997US5681961 Arylsulphonamides, pharmaceutical compositions containing these compounds and processes for preparing them
10/25/1997CA2203466A1 Novel specific immunophilin ligands as antiasthmatics and immunosuppressants
10/23/1997WO1997039126A1 Novel rantes homolog from prostate
10/23/1997WO1997038986A1 Substituted benzenesulfonamide derivatives as prodrugs of cox-2 inhibitors
10/23/1997WO1997038977A1 Aminoisoquinolines and aminothienopyridine derivatives and their use as anti-inflammatory agents
10/23/1997WO1997035005A3 Cftr gene regulator
10/23/1997CA2251681A1 Aminoisoquinolines and aminothienopyridine derivatives and their use as anti-inflammatory agents
10/23/1997CA2251115A1 Novel rantes homolog from prostate
10/22/1997EP0801656A1 Induction of cytotoxic t-lymphocyte responses
10/22/1997EP0801563A1 The use of 2,3-alkylcarbonyloxybenzoic acid in treating adult respiratory distress syndrome
10/22/1997EP0801554A1 Formulations and methods for reducing skin irritation
10/22/1997CN1162484A Compounded Chuanlin Dingchuan capsule for asthma
10/21/1997US5679692 Unbridged bis-aryl carbinol derivatives, compositions and methods of use
10/21/1997US5679678 Analgesic and antiinflammatory agents
10/21/1997US5679650 Pharmaceutical compositions including mixtures of an adenosine compound and a catecholamine
10/21/1997US5679339 Method of using IL-11 for treating spondyloarthropies
10/16/1997WO1997038084A2 Polynucleotides derived from a pbmc cdna library encoding secreted proteins
10/16/1997WO1997037681A1 Medicament for optimising mucosal viscosity and stimulating intestinal function
10/16/1997WO1997037678A1 Drug for the treatment of tumours
10/16/1997WO1997037666A1 Use of phosphinyloxyalkyl and phosphonamidoalkyl derivatives of cyclopentane(ene) as therapeutic agents
10/16/1997WO1997037665A1 Method of treating heart failure with endothelin antagonists
10/16/1997CA2251009A1 Medicament for optimising mucosal viscosity and stimulating intestinal function
10/16/1997CA2250860A1 Polynucleotides encoding secreted proteins
10/16/1997CA2250839A1 Drug for the treatment of tumours
10/15/1997EP0801135A1 Enzymatic resolution of endo-bicyclo (2.2.1)heptan-2-ol
10/15/1997EP0801132A2 Staphylococcal FtsH protein
10/15/1997EP0801067A1 Novel quinuclidine derivatives and medicinal composition thereof
10/15/1997EP0801060A1 Heterocyclic Beta-3 Adrenergenic Agonists
10/15/1997EP0800536A2 Recombinant il-5 antagonists useful in treatment of il-5 mediated disorders
10/15/1997EP0800517A1 Acetylenes disubstituted with a 5 or 8 substituted tetrahydronaphthyl or dihydronaphthyl group and with an aryl or heteroaryl groups having retinoid-like biological activity
10/15/1997CN1161855A Medicine for treating bronchitis of old people
10/14/1997US5677429 Vaccine
10/14/1997US5677419 Cyclic vasoactive peptide analogs
10/14/1997US5677324 Benzopyranes as potassium channel openers
10/14/1997US5677321 Anesthetic premedication
10/14/1997US5677317 Lactam compounds which are useful in the treatment of asthma
10/14/1997US5676930 Containing a medicine, a fluorohydrocarbon propellant, ethanol and either ascorbic or citric acid as stabilizer
10/14/1997US5676929 Canister containing aerosol formulations containing P134a and particulate medicaments
10/09/1997WO1997037026A1 Novel compounds
10/09/1997WO1997036905A1 Diazepino-indoles as phosphodiesterase iv inhibitors
10/09/1997WO1997036903A1 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
10/09/1997WO1997036871A1 6-phenylpyridyl-2-amine derivatives
10/09/1997WO1997031941A3 Soluble tachykinin antagonists, the preparation and use thereof
10/09/1997DE19613691A1 Arzneimittel für die Behandlung von Tumorerkrankungen Drugs for the treatment of tumor diseases
10/09/1997CA2250209A1 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
10/09/1997CA2220407A1 Diazepino-indoles as phosphodiesterase iv inhibitors
10/09/1997CA2201988A1 Heterocyclic .beta.-adrenergic agonists
10/08/1997EP0799823A1 1,2-Diphenylpyrrole derivatives, their preparation and their therapeutic uses
10/08/1997EP0799311A1 Human chemokine beta-9
10/08/1997EP0799225A1 Compounds and methods
10/08/1997EP0799198A1 Anti-inflammatory compounds
10/08/1997EP0799188A2 Amides of mono and bicarboxylic acids with amino acids or glycosamines, selectively active on the cannabinoid peripheral receptor
10/08/1997EP0799183A1 3,3-(disubstituted)cyclohexan-1-one monomers and related compounds
10/08/1997EP0799040A1 Trisubstituted thioxanthines
10/08/1997EP0799033A1 Use of mono and bicarboxylic acid amides for the manufacture of a medicament active at the peripheral cannabinoid receptor
10/08/1997CN1161337A Water soluble rapamycin esters
10/07/1997US5674913 Method for assisting normal breathing in a mammal having a lung disorder
10/07/1997US5674881 Quaternary ammonium salts of aromatic amine compounds, their preparation and pharmaceutical compositions in which they are present
10/07/1997US5674866 Antiallergic imidazoazepines
10/07/1997US5674860 Administering measured amounts of formoterol(or its salts or solvates) and budesonide by inhalation
10/07/1997US5674834 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same
10/07/1997US5674708 Amino acid at position 358 is selected from the group consisting of isoleucine, valine, alanine, aspartic acid, threonine and glutamic acid
10/07/1997US5674493 Compositions and methods for targeting cells with A2R and A2R monoclonal antibodies
10/07/1997US5674472 Drug delivery
10/02/1997WO1997035864A1 Phosphoramidates and phosphinic amides, their use to modulate the activity of endothelin
10/02/1997WO1997035854A1 Novel phenanthridines substituted in the 6 position
10/02/1997WO1997035591A2 Method of treating ciliary dyskinesia with uridine triphosphates and related compounds
10/02/1997WO1997035572A1 Carboxylic acid indole inhibitors of chemokines
10/02/1997WO1997035559A2 Manufacture of liposomes and lipid-protein complexes by ethanolic injection and thin film evaporation
10/02/1997WO1997035480A1 Method of treating common cold or allergic rhinitis
10/02/1997CA2249652A1 Method of treating common cold or allergic rhinitis
10/01/1997EP0797995A2 Use of a 5-HT2 receptor antagonist in the manufacture of a medicament for treating or ameliorating the symptoms of common cold or allergic rhinitis
10/01/1997EP0797988A2 Anti-angiogenic compositions and methods of use
10/01/1997EP0797666A2 Genetically engineered human-derived kunitz domains that inhibit human neutrophil elastase
10/01/1997EP0797431A1 Aerosol formulations of peptides and proteins
10/01/1997CN1161041A Heterocycle-condensed morphinoid derivatives
10/01/1997CN1161040A Bicyclic tetrahydro pyrazolopyridines and their use as medicaments
09/1997
09/30/1997US5672602 Substituted piperazine derivatives
09/30/1997US5672356 Bioadhesive pharmaceutical composition for the controlled release of active principles
09/30/1997CA2129676C Dextromethorphan antitussive compositions
09/25/1997WO1997035193A1 Cryptic peptides and method for their identification
09/25/1997WO1997035005A2 Cftr gene regulator
09/25/1997WO1997034885A1 Benzopyran derivatives having leukotriene-antagonistic action
09/25/1997WO1997034882A1 2-(3h)-oxazolone derivatives and their use as cox-2 inhibitors
09/25/1997WO1997034874A1 1,3,5-trisubstituted indazole derivatives with an anti-asthmatic, anti-allergic, anti-inflammatory and immunomodulating action
09/25/1997WO1997034871A1 Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders
09/25/1997WO1997034600A1 Preparation containing a combination of 5-methylisoxazole-4-carboxylic acid-(4-trifluoromethyl)-anilide and n-(4-trifluoromethylphenyl)2-cyano-3-hydroxycrotonic acid amide
09/25/1997WO1997017446A3 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF
09/25/1997DE19610955A1 Kombinationspräparat, enthaltend 5-Methylisoxazol-4-carbonsäure-(4-trifluormethyl)- anilid und N-(4-Trifluormethylphenyl)-2-cyan-3- hydroxycrotonsäureamid Combination preparation, comprising 5-methylisoxazole-4-carboxylic acid (4-trifluoromethyl) - anilide and N- (4-trifluoromethylphenyl) -2-cyano-3- hydroxycrotonamide
09/25/1997DE19610882A1 Neue 1,3,5-trisubstituierte Indazol-Derivate mit antiasthmatischer, antiallergischer, entzündungshemmender und immunmodulierender Wirkung, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel New 1,3,5-tri-substituted indazole derivatives having anti-asthmatic, anti-allergic, anti-inflammatory and immunomodulating effect, processes for their preparation and their use as medicaments
09/25/1997CA2249420A1 2-(3h)-oxazolone derivatives and their use as cox-2 inhibitors
09/24/1997EP0796866A1 Antithrombotic diamides
09/24/1997EP0796270A2 Peptide compounds for prevention and/or treatment of no-mediated diseases
09/24/1997EP0796250A1 Pyridazinones as endothelin-receptor antagonists